CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Oct. 25, 2025	Oct. 26, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$ 12,002	$ 12,803
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	8,905	8,955
Non-cash share-based compensation	913	862
Deferred taxes	309	(41)
Provision to value inventories at LIFO	242	118
Gain on sale of property, equipment and fixtures	(22)	0
Changes in assets and liabilities:
Merchandise inventories	(2,964)	(2,193)
Patronage dividend receivable	(5,460)	(5,564)
Accounts payable to Wakefern	(633)	516
Accounts payable and accrued expenses	2,462	1,005
Accrued wages and benefits	(1,736)	(666)
Income taxes receivable / payable	5,195	5,122
Other assets and liabilities	443	(742)
Net cash provided by operating activities	19,656	20,175
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures	(8,946)	(11,701)
Proceeds from the sale of assets	4,494	0
Investment in notes receivable from Wakefern	(2,110)	(2,202)
Investment in real estate partnership	0	(339)
Net cash used in investing activities	(6,562)	(14,242)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of stock options	0	21
Principal payments of long-term debt	(2,778)	(2,711)
Dividends	(3,326)	(3,324)
Net cash used in financing activities	(6,104)	(6,014)
NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS	6,990	(81)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	110,699	117,261
CASH AND CASH EQUIVALENTS, END OF PERIOD	117,689	117,180
SUPPLEMENTAL DISCLOSURES OF CASH  PAYMENTS MADE FOR:
Interest	862	990
Income taxes	0	769
NONCASH SUPPLEMENTAL DISCLOSURES:
Capital expenditures included in accounts payable and accrued expenses	7,087	9,290
Lease obligations obtained in exchange for right-of-use assets	$ 175	$ 0